Jerry R. Mendell - Concepedia

Author

Jerry R. Mendell

Also Known As

J Mendell, J R Mendell, J. Mendell, J. R. MENDELL, J. R. Mendell, J.R Mendell, J.R. Mendell, JERRY R. MENDELL, Jerry Mendell, Jerry R Mendell

290

Publications

20K

Citations

H-Index

216

Concepts

All Affiliations

The Ohio State University Nationwide Children's Hospital The University of Texas Southwestern Medical Center Novartis (United States)National Institutes of Health

About

Jerry R. Mendell is an author at The Ohio State University specializing in medicine, neuropathology, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	68	7.3K
2	Health Sciences	13	14	2.4K
3	Education	2	2	61
4	Natural Sciences	2	2	128
5	Engineering	1	1	83

Jerry R. Mendell

132

Publications

16.2K

Citations

H-Index

Page 1

	Year	Citations
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy Jerry R. Mendell, Samiah Al-Zaidy, Richard Shell, New England Journal of Medicine	2017	2.2K
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model Janaiah Kota, Raghu R. Chivukula, Kathryn A. O’Donnell, Cell Tumor BiologyMedicineLiver PhysiologyMicrorna DetectionLiver Cancer	2009	1.7K
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver Shu‐Hao Hsu, Bo Wang, Janaiah Kota, Journal of Clinical Investigation ImmunologyPathologyTumor BiologyOxidative StressEssential Metabolic	2012	775
Identification of Proximal Spinal Muscular Atrophy Carriers and Patients by Analysis of SMNT and SMNC Gene Copy Number Patricia McAndrew, D. Williams Parsons, Louise R. Simard, The American Journal of Human Genetics Genetic AnalysisSpinal Cord InjuryGenetic DisorderMedicineGenetics	1997	529
Microvascular Deposition of Complement Membrane Attack Complex in Dermatomyositis John T. Kissel, Jerry R. Mendell, Kottil Rammohan New England Journal of Medicine VasculitisImmunologyDermatologyCellular PhysiologyInflammation	1986	521
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial John Day, Richard S. Finkel, Claudia A. Chiriboga, The Lancet Neurology Rare DiseasesSpinal Cord InjuryMedicineDegenerative DiseaseNeurology	2021	449
Painful sensory neuropathy Magali Periquet, Vera Novak, Michael P. Collins, Neurology	1999	374
Clinical investigation in duchenne dystrophy: 2. Determination of the “power” of therapeutic trials based on the natural history Michael H. Brooke, Gerald M. Fenichel, Robert C. Griggs, Muscle & Nerve	1983	353
Systemic Gene Delivery in Large Species for Targeting Spinal Cord, Brain, and Peripheral Tissues for Pediatric Disorders Adam K. Bevan, Sandra Duqué, Kevin D. Foust, Molecular Therapy	2011	327
Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial Kevin A. Strauss, Michelle A. Farrar, Francesco Muntoni, Nature Medicine	2022	273

Page 1